Boudreau Philip P 4
4 · ABBOTT LABORATORIES · Filed Sep 6, 2023
Insider Transaction Report
Form 4
Boudreau Philip P
EVP AND CFO
Transactions
- Award
Option (right to buy)
2023-09-01+10,223→ 10,223 totalExercise: $103.18From: 2024-09-01Exp: 2033-08-31→ Common Shares (10,223 underlying) - Award
Common shares without par value
2023-09-01+2,620→ 18,067 total
Holdings
- 349(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of September 1, 2023.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 3,407 on September 1, 2024, 3,408 on September 1, 2025, and 3,408 on September 1, 2026.